Renal Cell Carcinoma Algorithm Defined in "Renal Cell Carcinoma Following At Least 180 Days of Canagliflozin Use in Patients with Type 2 Diabetes Mellitus: A Clone-Censor-Weighted Analysis with Inverse Probability of Treatment Weighting for Active Comparators"

This report lists International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) and International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) diagnosis codes, Current Procedural Terminology, Category II (CPT-2), Current Procedural Terminology, Category III (CPT-3), Current Procedural Terminology, Fourth Edition (CPT-4), Healthcare Common Procedure Coding System (HCPCS), International Classification of Diseases, Ninth Revision, Procedure Coding System (ICD-9-PCS), International Classification of Diseases, Tenth Revision, Procedure Coding System (ICD-10-PCS) procedure codes, generic and brand names of medical products, and algorithms used to define renal cell carcinoma outcomes in this request.

For additional information about the algorithm and how it was defined relative to the cohort and exposure(s) of interest in the analysis, refer to the analysis webpage here.